Introduction: Immunosuppression plays a central role in the pathogenesis of skin cancer in kidney transplant recipients. Recently, the potential for sirolimus to reduce the incidence of non-melanoma skin cancer in this population has been studied.Objective: To analyse the relationship between initial maintenance immunosuppressive regimens and the onset of non-melanoma skin cancer – squamous cell carcinoma and b...